United States: The 800,000-person pool of Americans will experience heart attacks and strokes during this year.
Heart disease has the potential to strike any individual, yet senior citizens face considerably increased susceptibility to this condition.
More about the news
Medical professionals prescribed low-dose aspirin (81 milligrams per day) to apparently healthy senior patients since the medication served as a blood thinner to prevent heart attack and stroke incidents.
Moreover, the American College of Cardiology, together with the American Heart Association, released new guidelines in 2019 against habitual aspirin consumption for healthy adults past 70 years of age because of bleeding risks, Daily Mail reported.

The US Preventive Services Task Force issued an official recommendation in 2022 for adults above 60 to abstain from aspirin usage as cardiovascular disease prevention.
A recent survey of US adults demonstrated that almost half (48 percent) mistakenly believed low-dose daily aspirin offers more advantages compared to risks when taken by most people.
What more are the experts stating?
According to Kathleen Hall Jamieson, director of the survey and of the Annenberg Public Policy Center of the University of Pennsylvania, “Habits backed by conventional wisdom and the past advice of health care providers are hard to break,” Daily Mail reported.
“Knowing whether taking a low-dose aspirin daily is advisable or not for you is vital health information,” Jamieson added.
Medical studies show that taking aspirin elevates brain and stomach bleeding danger while providing minimal protection against strokes.

Strokes are more likely to occur during the November to February months, potentially because holiday-related stress disrupts normal routines for many people.
The November research by Annenberg involved surveying 1,800 adults before releasing these results through publication this week. About 18 percent of adults in the United States without a heart attack or stroke background use aspirin regularly for its low-dose impact.
People under 40 displayed better comprehension of aspirin’s greater risks compared to its potential benefits, possibly because they were uninitiated by the initial recommendations.
Baby boomers aged between 18 and 39 who had no relevant medical history showed that 29 percent considered the risks too high but this percentage decreased among those in the 40 to 59 range at 11 percent and those aged 60 and up at 7 percent.